IRCM : One central theme & two unifying programs :
Molecular Targets and Cancer Therapy

Francais

Welcome to U1194 INSERM

 

«In just 20 years, the Institut de Recherche en Cancérologie de Montpellier (IRCM U1194) has raised its research to the highest international level in the field of fundamental and applied oncology, research carried out in close collaboration with the clinical departments of the Centre de Lutte Contre le Cancer de Montpellier (ICM: Institut du Cancer de Montpellier), and industrial partners. Jointly operated by Inserm, ICM and the University of Montpellier, the IRCM now brings together more than 200 people, researchers, clinicians, technicians and students, organised into 17 research teams supported by efficient technical platforms and support services. In an extremely competitive and rapidly evolving field of research, our greatest challenge is to stay one step ahead, seek excellence, accelerate innovation and transfer to the patient to ultimately help overcome the countless different forms of cancer.

Together, let's push the boundaries.»

 

Claude Sardet, Director of IRCM

 

 

 

The Cancer Research Institute of Montpellier U1194 jointly operated by Inserm, University of Montpellier and Institut du Cancer de Montpellier (CLCC) 

 

219 scientists and support personnel 

17 research teams sharing 5000 m2 of lab space

• Excellent core facilities, many being part of the shared facilities network Montpellier BioCampus

 

Biotech spin-offs 

• Ground breaking research in basic and translational oncology developed in close collaboration with clinical departments and clinical research at ICM 

 

 

One central theme and two unifying programs : Molecular Targets and Cancer Therapy

 

     1. Plasticity of solid tumors : from discoveries to personalized medecine


     2. Therapeutic Antibodies in Cancer Treatment : Innovation, design and biological response
 

 

Director - C. Sardet

Deputy Director - P. Martineau

Administrative Manager - S. Lannelongue

Medical Advisor - D. Azria

 

 

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Sign in - Conception : ID Alizés